Reply To: Traders Market Weekly: NVidia, AI and The Debt Celling


CVS Health (CVS) is reportedly closing down its clinical trials unit.

According to Endpoints News, the move is meant to allow the drug store chain to focus on its core business. The company plans a phased wind down that will lead to a full exit by the end of 2024.